Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17–21, 2014, Tübingen, Germany

Molecular Imaging and Biology

Volumn 17, Issue 3, 2015, Pages 297-312

  Bailey, D L ^a   Antoch, G ^b   Bartenstein, P ^c   Barthel, H ^d   Beer, A J ^e   Bisdas, S ^f   Bluemke, D A ^g   Boellaard, R ^h   Claussen, C D ^f   Franzius, C ⁱ   Hacker, M ^j   Hricak, H ^k   la Fougere C ^f   Guckel B ^f   Nekolla, S G ^l   Pichler, B J ^f   Purz, S ^d   Quick, H H ^m,n   Sabri, O ^d   Sattler, B ^d   Schafer J ^f   Schmidt, H ^f   van den Hoff, J ^o   Voss, S ^p   Weber, W ^k   Wehrl, H F ^f   Beyer, T ^j   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Center for Nuclear Medicine and PET/CT   (Germany)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^l TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^m UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁿ UNIVERSITY HOSPITAL ESSEN   (Germany)

^o Center for Neurodegenerative Diseases   (Germany)

^p BOSTON CHILDREN S HOSPITAL   (United States)

more..

Author keywords

Attenuation correction; Cardiology; Hybrid imaging; Molecular imaging; MRI; Neurology; Oncology; Paediatric oncology; PET; PET CT; PET MRI; Quantification

Indexed keywords

ANIMAL; CARDIOLOGY; GERMANY; HUMAN; IMAGE PROCESSING; MULTIMODAL IMAGING; NEUROLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALS; CARDIOLOGY; GERMANY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MEDICAL ONCOLOGY; MULTIMODAL IMAGING; NEUROLOGY; POSITRON-EMISSION TOMOGRAPHY;

EID: 84939954514     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-014-0818-0     Document Type: Review

References (78)

1. Bailey DL, Barthel H, Beyer T et al (2013) Summary report of the first international workshop on PET/MR imaging, march 19-23, 2012, Tubingen, Germany. Mol Imaging Biol MIB Off Publ Acad Mol Imaging 15:361–371
2. Bailey DL, Barthel H, Beuthin-Baumann B et al (2014) Combined PET/MR: where are we now? Summary report of the second international workshop on PET/MR imaging april 8–12, 2013, Tubingen, Germany. Mol Imaging Biol MIB Off Publ Acad Mol Imaging 16:295–310
3. 18F-FDG PET/CT in patients with head and neck cancer. Eur J Nucl Med Mol Imaging 41:639–648
4. Lee G, Kim IH, Kim SJ et al (2014) Clinical implication of PET/MR imaging in preoperative esophageal cancer staging: comparison with PET/CT, endoscopic ultrasonography, and CT. J Nucl Med Off Publ Soc Nucl Med 55:1242–1247
5. 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results. Invest Radiol 48:273–279
6. Hillner BE, Liu D, Coleman RE et al (2007) The national oncologic PET registry (NOPR): design and analysis plan. J Nucl Med Off Publ Soc Nucl Med 48:1901–1908
7. 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts. J Nucl Med Off Publ Soc Nucl Med 53:831–837
8. Hillner BE, Siegel BA, Liu D et al (2008) Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the national oncologic PET registry. J Clin Oncol Off J Am Soc Clin Oncol 26:2155–2161
9. Hillner BE, Siegel BA, Shields AF et al (2009) The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the national oncologic PET registry. Cancer 115:410–418
10. Aznar MC, Sersar R, Saabye J et al (2014) Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging. Eur J Radiol 83:1177–1183
11. Bezrukov I, Schmidt H, Mantlik F et al (2013) MR-based attenuation correction methods for improved PET quantification in lesions within bone and susceptibility artifact regions. J Nucl Med Off Publ Soc Nucl Med 54:1768–1774
12. Kuhn FP, Hullner M, Mader CE et al (2014) Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed? J Nucl Med Off Publ Soc Nucl Med 55:551–558
13. 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol 83:289–296
14. Preuss M, Werner P, Barthel H et al (2014) Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Child’s Nerv Syst ChNS Off J Int Soc Pediatr Neurosurg 30:1399–1403
15. Purz S, Sabri O, Viehweger A et al (2014) Potential pediatric applications of PET/MR. J Nucl Med Off Publ Soc Nucl Med 55:32S–39S
16. 18F-FDG-PET. JMRI-J Magn Reson Im
17. Bisdas S, Ritz R, Bender B et al (2013) Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes. Invest Radiol 48:295–301
18. Wetter A (2014) Molecular research in urology 2014: update on PET/MR imaging of the prostate. Int J Mol Sci 15:13401–13405
19. Wetter A, Lipponer C, Nensa F et al (2014) Evaluation of the PET component of simultaneous [(18) F] choline PET/MRI in prostate cancer: comparison with [(18) F] choline PET/CT. Eur J Nucl Med Mol Imaging 41:79–88
20. 18F] choline PET/MRI: combined SUV and ADC analysis. Ann Nucl Med 28:405–410
21. 18F] choline PET/MRI. PLoS One 9:e101571
22. 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience. Eur J Nucl Med Mol Imaging 41:887–897
23. Huellner MW, Appenzeller P, Kuhn FP, et al (2014) Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations. Radiology:140090
24. Martinez-Moller A, Souvatzoglou M, Delso G et al (2009) Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. J Nucl Med Off Publ Soc Nucl Med 50:520–526
25. Schramm G, Langner J, Hofheinz F et al (2013) Quantitative accuracy of attenuation correction in the Philips ingenuity TF whole-body PET/MR system: a direct comparison with transmission-based attenuation correction. MAGMA 26:115–126
26. Prieto E, Dominguez-Prado I, Garcia-Velloso MJ et al (2013) Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET. Clin Nucl Med 38:103–109
27. Nuyts J, Bal G, Kehren F et al (2013) Completion of a truncated attenuation image from the attenuated PET emission data. IEEE Trans Med Imaging 32:237–246
28. Nuyts J, Dupont P, Stroobants S et al (1999) Simultaneous maximum a posteriori reconstruction of attenuation and activity distributions from emission sinograms. IEEE Trans Med Imaging 18:393–403
29. Rezaei A, Defrise M, Bal G et al (2012) Simultaneous reconstruction of activity and attenuation in time-of-flight PET. IEEE Trans Med Imaging 31:2224–2233
30. Rezaei A, Defrise M, Nuyts J (2014) ML-reconstruction for TOF-PET with simultaneous estimation of the attenuation factors. IEEE Trans Med Imaging 33:1563–1572
31. Blumhagen JO, Braun H, Ladebeck R et al (2014) Field of view extension and truncation correction for MR-based human attenuation correction in simultaneous MR/PET imaging. Med Phys 41:022303
32. Kartmann R, Paulus DH, Braun H et al (2013) Integrated PET/MR imaging: automatic attenuation correction of flexible RF coils. Med Phys 40:082301
33. Defrise M, Rezaei A, Nuyts J (2012) Time-of-flight PET data determine the attenuation sinogram up to a constant. Phys Med Biol 57:885–899
34. Defrise M, Rezaei A, Nuyts J (2014) Transmission-less attenuation correction in time-of-flight PET: analysis of a discrete iterative algorithm. Phys Med Biol 59:1073–1095
35. Wurslin C, Schmidt H, Martirosian P et al (2013) Respiratory motion correction in oncologic PET using T1-weighted MR imaging on a simultaneous whole-body PET/MR system. J Nucl Med Off Publ Soc Nucl Med 54:464–471
36. Lougovski A, Hofheinz F, Maus J et al (2014) A volume of intersection approach for on-the-fly system matrix calculation in 3D PET image reconstruction. Phys Med Biol 59:561–577
37. Weber WA, Ziegler SI, Thodtmann R et al (1999) Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med Off Publ Soc Nucl Med 40:1771–1777
38. Ziegler S, Braun H, Ritt P et al (2013) Systematic evaluation of phantom fluids for simultaneous PET/MR hybrid imaging. J Nucl Med Off Publ Soc Nucl Med 54:1464–1471
39. Oehmigen M, Ziegler S, Jakoby BW et al (2014) Radiotracer dose reduction in integrated PET/MR: implications from National Electrical Manufacturers Association phantom studies. J Nucl Med Off Publ Soc Nucl Med 55:1361–1367
40. van den Hoff J, Oehme L, Schramm G et al (2013) The PET-derived tumor-to-blood standard uptake ratio (SUR) is superior to tumor SUV as a surrogate parameter of the metabolic rate of FDG. EJNMMI Res 3:77
41. van den Hoff J, Lougovski A, Schramm G et al (2014) Correction of scan time dependence of standard uptake values in oncological PET. EJNMMI Res 4:18
42. Heiss WD (2009) The potential of PET/MR for brain imaging. Eur J Nucl Med Mol Imaging 36(Suppl 1):S105–S112
43. Catana C, Drzezga A, Heiss WD, Rosen BR (2012) PET/MRI for neurologic applications. J Nucl Med Off Publ Soc Nucl Med 53:1916–1925
44. Drzezga A, Barthel H, Minoshima S, Sabri O (2014) Potential clinical applications of PET/MR imaging in neurodegenerative diseases. J Nucl Med Off Publ Soc Nucl Med 55:47S–55S
45. Garibotto V, Heinzer S, Vulliemoz S et al (2013) Clinical applications of hybrid PET/MRI in neuroimaging. Clin Nucl Med 38:13–18
46. Riedl V, Bienkowska K, Strobel C et al (2014) Local activity determines functional connectivity in the resting human brain: a simultaneous FDG-PET/fMRI study. J Neurosci Off J Soc Neurosci 34:6260–6266
47. 18F-FDG brain imaging in patients examined for suspected dementia. J Nucl Med Off Publ Soc Nucl Med 55:923–931
48. Andersen FL, Ladefoged CN, Beyer T et al (2014) Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone. Neuroimage 84:206–216
49. Poynton CB, Chen KT, Chonde DB et al (2014) Probabilistic atlas-based segmentation of combined T1-weighted and DUTE MRI for calculation of head attenuation maps in integrated PET/MRI scanners. Am J Nucl Med Mol Imaging 4:160–171
50. Stegger L, Martirosian P, Schwenzer N et al (2012) Simultaneous PET/MR imaging of the brain: feasibility of cerebral blood flow measurements with FAIR-TrueFISP arterial spin labeling MRI. Acta Radiol 53:1066–1072
51. Werner P, Fritzsch D, Holland H et al (2014) Definition of primary and secondary glioblastoma–letter. Clin Cancer Res An Off J Am Assoc Cancer Res 20:2011–2012
52. 18F-choline PET/MRI. Clin Nucl Med 39:e387–e388
53. Sander CY, Hooker JM, Catana C et al (2013) Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI. Proc Natl Acad Sci U S A 110:11169–11174
54. Kendziorra K, Wolf H, Meyer PM et al (2011) Decreased cerebral alpha4beta2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography. Eur J Nucl Med Mol Imaging 38:515–525
55. Deutschlander A, Stephan T, Riedel E et al (2008) Nicotine-induced nystagmus correlates with midpontine activation. Neuroimage 41:479–482
56. Mitsias PD, Ewing JR, Lu M et al (2004) Multiparametric iterative self-organizing MR imaging data analysis technique for assessment of tissue viability in acute cerebral ischemia. AJNR Am J Neuroradiol 25:1499–1508
57. Langer DL, van der Kwast TH, Evans AJ et al (2009) Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30:327–334
58. Liu X, Langer DL, Haider MA et al (2009) Prostate cancer segmentation with simultaneous estimation of Markov random field parameters and class. IEEE Trans Med Imaging 28:906–915
59. 11C-choline positron emission tomography. Cancer Res 73:1470–1480
60. Wehrl HF, Hossain M, Lankes K et al (2013) Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nat Med 19:1184–1189
61. 18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system. Invest Radiol 48:247–255
62. Dukart J, Mueller K, Horstmann A et al (2011) Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One 6:e18111
63. Hirsch FW, Sattler B, Sorge I et al (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43:860–875
64. Punwani S, Cheung KK, Skipper N et al (2013) Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease. Pediatr Radiol 43:941–949
65. Punwani S, Taylor SA, Saad ZZ et al (2013) Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI? Eur J Nucl Med Mol Imaging 40:373–385
66. Inaoka T, Takahashi K, Mineta M et al (2007) Thymic hyperplasia and thymus gland tumors: differentiation with chemical shift MR imaging. Radiology 243:869–876
67. Chawla SC, Federman N, Zhang D et al (2010) Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol 40:681–686
68. Rauscher I, Eiber M, Furst S et al (2014) PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT. J Nucl Med Off Publ Soc Nucl Med 55:724–729
69. 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581–1588
70. Schafer JF, Gatidis S, Schmidt H et al (2014) Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology 273:220–231
71. Lassmann M, Biassoni L, Monsieurs M et al (2008) The new EANM paediatric dosage card: additional notes with respect to F-18. Eur J Nucl Med Mol Imaging 35:1666–1668
72. Lassmann M, Treves ST (2014) Pediatric Radiopharmaceutical Administration: harmonization of the 2007 EANM Paediatric Dosage Card (Version 1.5.2008) and the (2010) North american consensus guideline. Eur J Nucl Med Mol Imaging 41:1636
73. 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol 59:1539–1548
74. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet 383:705–713
75. Mewton N, Liu CY, Croisille P et al (2011) Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 57:891–903
76. Muzard J, Sarda-Mantel L, Loyau S et al (2009) Non-invasive molecular imaging of fibrosis using a collagen-targeted peptidomimetic of the platelet collagen receptor glycoprotein VI. PLoS One 4:e5585
77. Schlemmer HP, Pichler BJ, Schmand M et al (2008) Simultaneous MR/PET imaging of the human brain: feasibility study. Radiology 248:1028–1035
78. Schmand M, Burbar Z, Corbeil JL et al (2007) BrainPET: first human tomograph for simultaneous (functional) PET and MR Imaging. J Nucl Med Off Publ Soc Nucl Med 48:45P